Literature DB >> 7744804

Proteolytic footprinting of vaccinia topoisomerase bound to DNA.

J Sekiguchi1, S Shuman.   

Abstract

Vaccinia DNA topoisomerase, a member of the eukaryotic type I enzyme family, binds duplex DNA and forms a covalent protein.DNA complex at sites containing a conserved sequence element 5'-CCCTT decreases. The structure of the enzyme in the free and DNA-bound states was probed by limited proteolysis. The free topoisomerase (a 314-amino acid polypeptide) consists of protease-resistant amino- and carboxyl-terminal structural domains flanking a protease-sensitive "hinge." The hinge region, located between residues 135 and 142, is defined by accessibility to three different proteases. The amino-terminal region is punctuated by a trypsin-sensitive "bridge" at Arg-80, suggesting at least a tripartite domain structure overall. A specific subset of residues accessible to proteases in the free enzyme becomes resistant to proteolysis in the DNA-bound state. The trypsin-sensitive site at Arg-80 is protected almost completely in the covalent complex. Within the hinge region, Lys-135, Tyr-136, and Glu-139 are protected from trypsin, chymotrypsin, and V8, respectively. Acquisition of altered protease sensitivity upon DNA binding occurs prior to covalent adduct formation. The 20-kDa carboxyl domain by itself binds noncovalently to duplex DNA, albeit without the sequence specificity characteristic of the full-sized topoisomerase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744804     DOI: 10.1074/jbc.270.19.11636

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Recombinogenic flap ligation pathway for intrinsic repair of topoisomerase IB-induced double-strand breaks.

Authors:  C Cheng; S Shuman
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Mechanism of DNA transesterification by vaccinia topoisomerase: catalytic contributions of essential residues Arg-130, Gly-132, Tyr-136 and Lys-167.

Authors:  J Wittschieben; S Shuman
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  Mutational analysis of vaccinia virus topoisomerase identifies residues involved in DNA binding.

Authors:  J Sekiguchi; S Shuman
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

4.  Major groove interactions of vaccinia Topo I provide specificity by optimally positioning the covalent phosphotyrosine linkage.

Authors:  Rajesh Nagarajan; James T Stivers
Journal:  Biochemistry       Date:  2006-05-09       Impact factor: 3.162

5.  Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.

Authors:  Lyudmila Yakovleva; Shengxi Chen; Sidney M Hecht; Stewart Shuman
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

6.  Intramolecular synapsis of duplex DNA by vaccinia topoisomerase.

Authors:  S Shuman; D G Bear; J Sekiguchi
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

7.  Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme.

Authors:  L Yu; A Martins; L Deng; S Shuman
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Crystal structure of a bacterial topoisomerase IB in complex with DNA reveals a secondary DNA binding site.

Authors:  Asmita Patel; Lyudmila Yakovleva; Stewart Shuman; Alfonso Mondragón
Journal:  Structure       Date:  2010-06-09       Impact factor: 5.006

9.  Resolution of Holliday junctions by eukaryotic DNA topoisomerase I.

Authors:  J Sekiguchi; N C Seeman; S Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

10.  Identification of contacts between topoisomerase I and its target DNA by site-specific photocrosslinking.

Authors:  J Sekiguchi; S Shuman
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.